Bank Of America Corp Immunity Bio, Inc. Transaction History

Bank Of America Corp

$1.33 Trillion
Q2 2025

A detailed history of Bank Of America Corp transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 8,756,183 shares of IBRX stock, worth $21.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,756,183

Previous 539,643 1522.59%

Holding current value

$21.6 Million

Previous $1.62 Million 1323.4%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$1.89 - $3.44 $15.5 Million - $28.3 Million	8,216,540 Added 1522.59%	8,756,183 $23.1 Million
Q1 2025 May 15, 2025	BUY	$2.32 - $3.9 $647,071 - $1.09 Million	278,910 Added 106.97%	539,643 $1.62 Million
Q4 2024 Feb 14, 2025	SELL	$2.56 - $6.17 $4.63 Million - $11.2 Million	-1,809,047 Reduced 87.4%	260,733 $667,000
Q3 2024 Nov 14, 2024	BUY	$3.32 - $6.7 $3.69 Million - $7.45 Million	1,111,253 Added 115.93%	2,069,780 $7.68 Million
Q2 2024 Aug 14, 2024	SELL	$4.82 - $9.15 $377,222 - $716,097	-78,262 Reduced 7.55%	958,527 $6.06 Million
Q1 2024 May 15, 2024	BUY	$3.23 - $6.17 $468,266 - $894,489	144,974 Added 16.26%	1,036,789 $5.57 Million
Q4 2023 Feb 14, 2024	BUY	$1.25 - $5.21 $998,435 - $4.16 Million	798,748 Added 858.25%	891,815 $4.48 Million
Q2 2023 Aug 14, 2023	SELL	$1.53 - $6.41 $124,632 - $522,152	-81,459 Reduced 46.67%	93,067 $258,000
Q1 2023 May 12, 2023	SELL	$1.35 - $4.78 $794,161 - $2.81 Million	-588,268 Reduced 77.12%	174,526 $317,000
Q4 2022 Feb 10, 2023	BUY	$4.35 - $6.77 $2.04 Million - $3.18 Million	469,444 Added 160.03%	762,794 $3.87 Million
Q3 2022 Nov 14, 2022	BUY	$3.65 - $6.43 $897,100 - $1.58 Million	245,781 Added 516.68%	293,350 $1.46 Million
Q2 2022 Aug 12, 2022	SELL	$2.68 - $6.14 $22,319 - $51,133	-8,328 Reduced 14.9%	47,569 $176,000
Q1 2022 May 16, 2022	SELL	$5.05 - $7.53 $536,769 - $800,371	-106,291 Reduced 65.54%	55,897 $314,000
Q4 2021 Feb 08, 2022	BUY	$5.67 - $10.18 $465,240 - $835,299	82,053 Added 102.39%	162,188 $987,000
Q3 2021 Nov 15, 2021	BUY	$9.17 - $14.24 $218,658 - $339,552	23,845 Added 42.36%	80,135 $780,000
Q2 2021 Sep 13, 2021	BUY	$13.41 - $22.4 $754,848 - $1.26 Million	56,290 New	56,290 $804,000

Others Institutions Holding IBRX

# of Institutions

275

Shares Held

111M

Call Options Held

1.99M

Put Options Held

3.09M

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $989M
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Immunity Bio, Inc. Transaction History